ML20199D147: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot insert)
 
(StriderTol Bot change)
 
(One intermediate revision by the same user not shown)
Line 17: Line 17:


=Text=
=Text=
{{#Wiki_filter:0                                                               . A i i u :.
{{#Wiki_filter:0
                                                                                              ..L L' f i'.E..i_*1 E_ _W h_ri. A_%M_M_*#4 W __A__.. W' Dr'                                                                                                       N              * -
. A i i u :.
                            ,                                U.S. NUCLf. AR REGULATORY COMMISSl!N                                 -
..L L' f i'.E..i_*1 E_ _W h_ri. A_%M_M_*#4 W A__.. W' Dr' U.S. NUCLf. AR REGULATORY COMMISSl!N N
N5 g
N5 g
l,d                 .                                    MATERIALS LICENSE                                                                       I g
l,d MATERIALS LICENSE I
Pursuant.to the Atemic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Pubbe Law 93-438). and Title 10, I i
g Pursuant.to the Atemic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Pubbe Law 93-438). and Title 10, I
Code of Federal Regulations, Chapter 1, Parts 30,31,32,33,34,35,40 and 70, and in rehance on statements and representations heretofore made by the licensee. a license is hereby issued authorizi. g the licensee to receive, acquire, possess, and transfer byproduct, f
i Code of Federal Regulations, Chapter 1, Parts 30,31,32,33,34,35,40 and 70, and in rehance on statements and representations f heretofore made by the licensee. a license is hereby issued authorizi. g the licensee to receive, acquire, possess, and transfer byproduct,y j sot.rce, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below; to l
y j sot.rce, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below; to       l deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This l l license shdi be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and I is subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any
deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This l
    ,        conditions specified below.
l license shdi be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is I
subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below.
4 Licensee E
4 Licensee E
      %j1                                                                                                                                                  l
%j l
: 3. License number                   SNM-1948                             5 h.WestVirginiaUniversityHospitals,Inc.
h.WestVirginiaUniversityHospitals,Inc.
Radiology Department                                                                                                                     ,I e
1
ll2. Medical Center Box 6401                                               ' E^                                                                     l Morgantown, West Virginia 2650                     f-{'          '
: 3. License number SNM-1948 5
4.hpN.h!e ti    p            February 28, 1987 1;
Radiology Department
ll h                      5. Docket or 7 070-03017/SNM - 1713 Reference No.           /,_                                         l r
,I e
lj 6. Byproduct, source, and/or                           7. Chemical and/or physical                     U. Maximum amount that licensee           i 5         special nuclear material                 1-        form                                           -
l ll2. Medical Center Box 6401
may possess at any one time         I f\\                                                                                           .{ / [jpder this license N
' E^
kJ    \)
Morgantown, West Virginia 2650 f-{'
                                                                                                        /                                                 l
4.hpN.h!e February 28, 1987 ti p
      \
1; h
I       A. Plutonium (Princp,a1 I          A.y                    ,
: 5. Docket or 7 070-03017/SNM - 1713 l
                                                                                                      .:              O                                  n g q       d           cs       y i             A.   {.2 grams (20 individual             t l                radionuclide Pu 238)                     p'             m, p                    s,qdrcesnottoexceed                I l                                   -
ll Reference No.
                                                                      %                                  ,1       :
/,_
: 9. Authorized use             "'
r lj 6. Byproduct, source, and/or
g^g%
: 7. Chemical and/or physical U. Maximum amount that licensee i
1, f           Q3             {                                   y dc fi
5 special nuclear material form
                                                                                                                                                  ~
.{ / [jpder this license may possess at any one time I
              . A.     Implanation in h               sa                                       MJ        Model          0 Nuclear powered              t cardiac pacemakers
f kJ \\)
(::                                              [cli r
1-
va}///t L        d N NUulti q urppsts.         $                                        I i
\\\\
9                 CO yNDI IONS
N
                                                                                                  ~
/
s l
l O
lj          10. Licensed material shall be usk-ogly Ja WesthginiaUniversityHospitals,Inc.,                                                         6 Morgantown, West Virginia.                         A Kh                                                                             j
\\
    !!          11. The specified possession limit includes all licensed material possessed by the l                   licensee under this license whether in storage, implanted in patients or other-                                                     l g
I A.y n
I                  wise in use.                                                                                                                       g I
I l
I           12.
A.
The licensee shall not receive or transfer in any single transaction one (1) gram                                                   l l                   or more of plutonium 238 contained in nuclear powered pacemakers without notifying                                                 I l                   the Division of Safeguards, U.S. Nuclear Regulatory Commission, Washington, D.C.
Plutonium (Princp,a1 g q d
q 20555, and, in addition, completing and distributing Form NRC-741 as required by                                                   l l;i                                                                                                                                                   y Section 70.54 of 10 CFR 70.                                                                                                       p 11 g
cs y i A.
k           13. The licensee shall report to the Material Licensing Branch, U.S. Nuclear Regulatory I                                                     !
{.2 grams (20 individual t
f                   Commission, Division of Fuel Cycle and Material Safety, Washington, D.C. 20555,                                                   I i                   within twenty-four (24) hours of occurrence, the death of any nuclear pacemaker i                   patient, and any adverse reaction and/or malfunction involving a pacemaker system, ly                                                    *l l                    including the leads. A written report giving details of the adverse reaction and/or                                                       '
p s,qdrcesnottoexceed I
i l
radionuclide Pu 238) p' m,
i              malfunction shall be submitted within thirty (30) days.                                                                           I l
l
a606200053 e60409                                                                                                     4           l REG 2 LIC70                                                                                                           C'         I
,1 1,
              ===      SNM-1948                 ,dD]_ _ __ _ _ _
9.
Authorized use g^g%
f Q3
{
y dc fi MJ Model 0 Nuclear powered t
. A.
Implanation in h sa
~
va}///t d N NUulti q urppsts.
I cardiac pacemakers r
(::
[cli i
L 9
CO yNDI IONS o
l
~
s Licensed material shall be usk-ogly Ja WesthginiaUniversityHospitals,Inc.,
lj 10.
6 Morgantown, West Virginia.
A Kh j
11.
The specified possession limit includes all licensed material possessed by the l
l licensee under this license whether in storage, implanted in patients or other-g I
wise in use.
I g
I 12.
The licensee shall not receive or transfer in any single transaction one (1) gram l
l or more of plutonium 238 contained in nuclear powered pacemakers without notifying I
l the Division of Safeguards, U.S. Nuclear Regulatory Commission, Washington, D.C.
l q
20555, and, in addition, completing and distributing Form NRC-741 as required by l;i Section 70.54 of 10 CFR 70.
y 11 p
k 13.
The licensee shall report to the Material Licensing Branch, U.S. Nuclear Regulatory I
g f
Commission, Division of Fuel Cycle and Material Safety, Washington, D.C.
: 20555, I
i within twenty-four (24) hours of occurrence, the death of any nuclear pacemaker i
patient, and any adverse reaction and/or malfunction involving a pacemaker system, l
* y l
including the leads.
A written report giving details of the adverse reaction and/or i
l malfunction shall be submitted within thirty (30) days.
I i
a606200053 e60409 4
l l
REG 2 LIC70 C'
I SNM-1948
,dD]_ _ __ _ _ _
 
===
L
L


                        .            .          ..                                                      .                                  1 7_._.__                     . _ .
1 7_._.__
m, m, ,e ,.9   _,; .g.4 L Fgm o,                     U.S. P.UCLE Ah ... ...a Al un , s w..m.u6vh3 ;                         g         g             g 1                 o                                                                   i u ns r.umhr
m, m,,e,.9
                ,                                                                                                                          l l'       *          .        MATERIALS LICENSE                                                         SNM - 1948                     l ll
_,;.g.4 L Fgm o, U.S. P.UCLE Ah......a Al un, s w..m.u6vh3 ;
* SUPPLEMENTARY SHEET                                                                                         l g,             ,
g g
                                                                .                                            070-03017                     ;
g 1
l'                                                                                                                                       L i                                                                                                         SNM - 1713                     l 1                                                                                                                                       I I                                                                                                                                       I f(cont'd)                                                       CONDITIONS
o i u ns r.umhr l
l' MATERIALS LICENSE SNM - 1948 l
ll
* SUPPLEMENTARY SHEET l
g, 070-03017 l'
L i
SNM - 1713 l
1 I
I I
f(cont'd)
[
CONDITIONS l
r q 14.
The licensee shall report to the Material Licensing Branch, Division of fuel Cycle p
i and Material Safety, U.S.
Nuclear Regulatory Commission, Washington, D.C.
: 20555, t
1l within ten (10) days, loss of contact with a nuclear pacemaker patient.
f ll L
li 15.
The licensee shall continue patient follow-up and replacement procedures for the f
i nuclear pacemaker during the life of the patient.
Procedures for recovery and gl authorized disposal of the nuclear pacemaker by return to the manufacturer shall p
l be followed upon the death of the efj {G 1
ll16.
Except as specifically prov d otherwise by t )i[Jjcense, the licensee shall l
l possess and use licensed.Mterial described in ItemsT6),7, and 8 of this license I
i f
in accordance with s4*athments, representations, and 'ppo9edures contained in L
l' application and {{letter dated|date=February 14, 1977|text=letter dated February 14, 1977}} signed Wadir Khuri, M.D., and
(
I!
others and Eugene Sta;iles,. Administrator; letters dated Must 10, 1977 signed
[
Hl M. Douglas Allan, gnuary'
*1982 signed Thoma fnay,41.D., and others and
[
[
l                                                                                                                                       r q 14.          The licensee shall report to the Material Licensing Branch, Division of fuel Cycle                                        p i                and Material Safety, U.S.          Nuclear Regulatory Commission, Washington, D.C.                        20555,      t -
l W. Robert Biddingt%; D.D.h, tprim Vice Pr t',
1l              within ten (10) days, loss of contact with a nuclear pacemaker patient.                                                  f ll                                                                                                                                      L li 15. The            licensee shall continue patient follow-up and replacement procedures for the nuclear pacemaker during the life of the patient.                                                                        f i                                                                                            Procedures for recovery and            p gl l              authorized        disposal  of  the nuclear        pacemaker          by    return    to the manufacturer shall        ;
Decembqr 12, 1984 signed I
be followed upon the death of the efj {G                                                          1 ll16.          Except as specifically prov                d otherwise by t )i[Jjcense, the licensee shall                            l l  i possess and use licensed.Mterial described in ItemsT6),7, and 8 of this license                                          I f              in accordance with s4*athments, representations, and 'ppo9edures contained in application and letter dated February 14, 1977 signed Wadir Khuri, M.D. , and L
fl William E. Collinh Ph.D.,
l'                                                                                                                                      (
zSt phe $ )S1 c h'. D., Makd1, 1985 signed I
I!              others and Eugene Sta;iles, . Administrator; letters dated Must 10, 1977 signed                                          [
William E. Colli Ph.D.,a[id y en a ',1 Q
Hl              M. Douglas Allan, gnuary' *1982 signed Thoma                                  '
ll The Nuclear Reg @etory Comm k
fnay,41.D. , and others and        [
regula
l              W. Robert Biddingt%; D.D.h,                     tprim Vice Pr                   t', Decembqr 12, 1984 signed           I fl             William E. Collinh Ph.D. ,                     zSt phe $ )S1 c                 h'. D . , Makd1, 1985 signed             I William E. Colli           Ph.D.,a[id y en                       a ' ,1         .
' Jihal),goved the licensee's L
Q ll I!
I!
The Nuclear Reg @etory Comm statements in appPicatihdiitr'l tter tuth k         regula         ' Jihal) ,goved the licensee's L
statements in appPicatihdiitr'l tter tuth g[.4 e~s%tements7re more restrictiv
[
[
l             than the regulatiYn's.           g4%                             g[.4 e~s%tements7re g
l than the regulatiYn's.
more restrictiv  f t
g4%
1 o                                           s                                       t l
g f
1 K %dt<                                                                       lt I                                                                                                                                       L I
t 1
1, l                                                                                        l l
o s
t l
K %dt<
l 1
t I
L I
l l
1, l
I L
I L
3 i
3 i
l                                                         FOR THE U.S. NUCLEAR REGULATORY COMMISSION f
l FOR THE U.S. NUCLEAR REGULATORY COMMISSION f
1 i
1 i
I                                                                                 EARL G. WRIGHT                                       t g;
I EARL G. WRIGHT t
Date        R 09 1985                            By            [ct[ M/ MMdf Region II, Nuclear Matfr,fals t
[ct[ M/ MMdf R 09 1985 Date t
y                                                                     Safety Section                                                 (
By g;
g 1,                                                                 101 Marietta Street, Suite 2900                                   l I;                                                                 Atlanta, GA 30323                                                 l l i L
Region II, Nuclear Matfr,fals
l'                                                                                                                                     l I                                                                                                                                     r I,
(
y Safety Section g
1, 101 Marietta Street, Suite 2900 l
I; Atlanta, GA 30323 l
l i L
l' l
I r
I,
[
[
li                                                                                                                                     L NfCMWMMMMMwMMW KTKiiiYrMK+W.#KiinDnwM.WMM@ ## w.w = Mr#CiwXiM.'niwaviib
li L
NfCMWMMMMMwMMW KTKiiiYrMK+W.#KiinDnwM.WMM@ ## w.w = Mr#CiwXiM.'niwaviib
.}}
.}}

Latest revision as of 08:16, 10 December 2024

License SNM-1948 for West Virginia Univ Hosps,Inc, Authorizing Use of Pu-238 for Implantation in Humans as Component of Medtronic Model 9000 nuclear-powered Cardiac Pacemakers for Clinical Evaluation Purposes
ML20199D147
Person / Time
Site: 07003017
Issue date: 04/09/1986
From: Wright E
NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION II)
To:
Shared Package
ML20199D148 List:
References
NUDOCS 8606200053
Download: ML20199D147 (2)


Text

{{#Wiki_filter:0 . A i i u :. ..L L' f i'.E..i_*1 E_ _W h_ri. A_%M_M_*#4 W A__.. W' Dr' U.S. NUCLf. AR REGULATORY COMMISSl!N N N5 g l,d MATERIALS LICENSE I g Pursuant.to the Atemic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Pubbe Law 93-438). and Title 10, I i Code of Federal Regulations, Chapter 1, Parts 30,31,32,33,34,35,40 and 70, and in rehance on statements and representations f heretofore made by the licensee. a license is hereby issued authorizi. g the licensee to receive, acquire, possess, and transfer byproduct,y j sot.rce, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below; to l deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This l l license shdi be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is I subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. 4 Licensee E %j l h.WestVirginiaUniversityHospitals,Inc. 1

3. License number SNM-1948 5

Radiology Department ,I e l ll2. Medical Center Box 6401 ' E^ Morgantown, West Virginia 2650 f-{' 4.hpN.h!e February 28, 1987 ti p 1; h

5. Docket or 7 070-03017/SNM - 1713 l

ll Reference No. /,_ r lj 6. Byproduct, source, and/or

7. Chemical and/or physical U. Maximum amount that licensee i

5 special nuclear material form .{ / [jpder this license may possess at any one time I f kJ \\) 1- \\\\ N / l O \\ I A.y n I l A. Plutonium (Princp,a1 g q d cs y i A. {.2 grams (20 individual t p s,qdrcesnottoexceed I radionuclide Pu 238) p' m, l ,1 1, 9. Authorized use g^g% f Q3 { y dc fi MJ Model 0 Nuclear powered t . A. Implanation in h sa ~ va}///t d N NUulti q urppsts. I cardiac pacemakers r (:: [cli i L 9 CO yNDI IONS o l ~ s Licensed material shall be usk-ogly Ja WesthginiaUniversityHospitals,Inc., lj 10. 6 Morgantown, West Virginia. A Kh j 11. The specified possession limit includes all licensed material possessed by the l l licensee under this license whether in storage, implanted in patients or other-g I wise in use. I g I 12. The licensee shall not receive or transfer in any single transaction one (1) gram l l or more of plutonium 238 contained in nuclear powered pacemakers without notifying I l the Division of Safeguards, U.S. Nuclear Regulatory Commission, Washington, D.C. l q 20555, and, in addition, completing and distributing Form NRC-741 as required by l;i Section 70.54 of 10 CFR 70. y 11 p k 13. The licensee shall report to the Material Licensing Branch, U.S. Nuclear Regulatory I g f Commission, Division of Fuel Cycle and Material Safety, Washington, D.C.

20555, I

i within twenty-four (24) hours of occurrence, the death of any nuclear pacemaker i patient, and any adverse reaction and/or malfunction involving a pacemaker system, l

  • y l

including the leads. A written report giving details of the adverse reaction and/or i l malfunction shall be submitted within thirty (30) days. I i a606200053 e60409 4 l l REG 2 LIC70 C' I SNM-1948 ,dD]_ _ __ _ _ _

=

L

1 7_._.__ m, m,,e,.9 _,;.g.4 L Fgm o, U.S. P.UCLE Ah......a Al un, s w..m.u6vh3 ; g g g 1 o i u ns r.umhr l l' MATERIALS LICENSE SNM - 1948 l ll

  • SUPPLEMENTARY SHEET l

g, 070-03017 l' L i SNM - 1713 l 1 I I I f(cont'd) [ CONDITIONS l r q 14. The licensee shall report to the Material Licensing Branch, Division of fuel Cycle p i and Material Safety, U.S. Nuclear Regulatory Commission, Washington, D.C.

20555, t

1l within ten (10) days, loss of contact with a nuclear pacemaker patient. f ll L li 15. The licensee shall continue patient follow-up and replacement procedures for the f i nuclear pacemaker during the life of the patient. Procedures for recovery and gl authorized disposal of the nuclear pacemaker by return to the manufacturer shall p l be followed upon the death of the efj {G 1 ll16. Except as specifically prov d otherwise by t )i[Jjcense, the licensee shall l l possess and use licensed.Mterial described in ItemsT6),7, and 8 of this license I i f in accordance with s4*athments, representations, and 'ppo9edures contained in L l' application and letter dated February 14, 1977 signed Wadir Khuri, M.D., and ( I! others and Eugene Sta;iles,. Administrator; letters dated Must 10, 1977 signed [ Hl M. Douglas Allan, gnuary'

  • 1982 signed Thoma fnay,41.D., and others and

[ l W. Robert Biddingt%; D.D.h, tprim Vice Pr t', Decembqr 12, 1984 signed I fl William E. Collinh Ph.D., zSt phe $ )S1 c h'. D., Makd1, 1985 signed I William E. Colli Ph.D.,a[id y en a ',1 Q ll The Nuclear Reg @etory Comm k regula ' Jihal),goved the licensee's L I! statements in appPicatihdiitr'l tter tuth g[.4 e~s%tements7re more restrictiv [ l than the regulatiYn's. g4% g f t 1 o s t l K %dt< l 1 t I L I l l 1, l I L 3 i l FOR THE U.S. NUCLEAR REGULATORY COMMISSION f 1 i I EARL G. WRIGHT t [ct[ M/ MMdf R 09 1985 Date t By g; Region II, Nuclear Matfr,fals ( y Safety Section g 1, 101 Marietta Street, Suite 2900 l I; Atlanta, GA 30323 l l i L l' l I r I, [ li L NfCMWMMMMMwMMW KTKiiiYrMK+W.#KiinDnwM.WMM@ ## w.w = Mr#CiwXiM.'niwaviib .}}